| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1897.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti (R.M., F.B., E.B., R.D.M., R.M.M., G.T.); Ospedale Civile, Caserta (C.C.); Ospedale Civile, Lanciano (D.D.G., L.M., G.M., C.T.); Department of Cardiovascular Research, Istituto Mario Negri, Milano (M.G.F.); Ospedale Cervello, Palermo (E.G.); Ospedale Civile, Vasto (G.L.); Centro Studi ANMCO, Firenze (A.P.M.); Ospedale Civile, Napoli (N.M.); Ospedale S. Maria degli Angeli, Pordenone (G.L.N.); Ospedale San Filippo Neri, Roma (M.S.); Ospedale Civile, Presidio di Riabilitazione, Passirana di Rho, Milano (C.S.); and IRCCS Policlinico San Matteo, Pavia (L.T.); Ospedale San Gerardo Nuovo, Monza (F.V.), Italy.
Correspondence to Roberto Marchioli, MD, GISSI-Prevenzione Secretariat, Consorzio Mario Negri Sud, Via Nazionale, 66030 Santa Maria Imbaro, Italy. E-mail marchioli{at}negrisud.it
Background Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction.
Methods and Results In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P=0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P=0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths.
Conclusions The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.
Key Words: fatty acids death, sudden trials coronary disease antiarrhythmia agents
This article has been cited by other articles:
![]() |
P. M Kris-Etherton Adherence to dietary guidelines: benefits on atherosclerosis progression Am. J. Clinical Nutrition, July 1, 2009; 90(1): 13 - 14. [Full Text] [PDF] |
||||
![]() |
P. J Smith, J. A Blumenthal, M. A Babyak, A. Georgiades, A. Sherwood, M. H Sketch Jr, and L. L Watkins Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1315 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Harris, D. Mozaffarian, M. Lefevre, C. D. Toner, J. Colombo, S. C. Cunnane, J. M. Holden, D. M. Klurfeld, M. C. Morris, and J. Whelan Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids J. Nutr., April 1, 2009; 139(4): 804S - 819S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Fruchart, F. M Sacks, M. P Hermans, G. Assmann, W V. Brown, R. Ceska, M J. Chapman, P. M Dodson, P. Fioretto, H. N Ginsberg, et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 319 - 335. [Abstract] [PDF] |
||||
![]() |
D. J. Becker, R. Y. Gordon, P. B. Morris, J. Yorko, Y. J. Gordon, M. Li, and N. Iqbal Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial Mayo Clin. Proc., July 1, 2008; 83(7): 758 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, Y. Ishikawa, M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Saito, Y. Matsuzawa, J. Sasaki, S. Oikawa, H. Hishida, et al. Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial Stroke, July 1, 2008; 39(7): 2052 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A Jacobson Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1981S - 1990S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mozaffarian Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1991S - 1996S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S Harris The omega-3 index as a risk factor for coronary heart disease Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1997S - 2002S. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grundt and D. W.T. Nilsen n-3 fatty acids and cardiovascular disease Haematologica, June 1, 2008; 93(6): 807 - 812. [Full Text] [PDF] |
||||
![]() |
B. E. Cohen, S. K. Garg, S. Ali, W. S. Harris, and M. A. Whooley Red Blood Cell Docosahexaenoic Acid and Eicosapentaenoic Acid Concentrations Are Positively Associated with Socioeconomic Status in Patients with Established Coronary Artery Disease: Data from the Heart and Soul Study J. Nutr., June 1, 2008; 138(6): 1135 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. O'Keefe, J. H. Lee, R. Marchioli, C. J. Lavie, and W. S. Harris Are All Fish Equally Close to the Heart?-Reply Mayo Clin. Proc., June 1, 2008; 83(6): 724 - 725. [Full Text] [PDF] |
||||
![]() |
S. Jew, C. A. Vanstone, J.-M. Antoine, and P. J. H. Jones Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions J. Nutr., June 1, 2008; 138(6): 1228S - 1236S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Feagan, W. J. Sandborn, U. Mittmann, S. Bar-Meir, G. D'Haens, M. Bradette, A. Cohen, C. Dallaire, T. P. Ponich, J. W. D. McDonald, et al. Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease: The EPIC Randomized Controlled Trials JAMA, April 9, 2008; 299(14): 1690 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, J. H. O'Keefe, C. J. Lavie, R. Marchioli, and W. S. Harris Omega-3 Fatty Acids for Cardioprotection Mayo Clin. Proc., March 1, 2008; 83(3): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fischer, R. Dechend, F. Qadri, M. Markovic, S. Feldt, F. Herse, J.-K. Park, A. Gapelyuk, I. Schwarz, U. B. Zacharzowsky, et al. Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension Hypertension, February 1, 2008; 51(2): 540 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J.A. Jenkins MD PhD, A. R. Josse MSc, J. Beyene PhD, P. Dorian MD MSc, M. L. Burr MD DSc (Me, R. LaBelle BSc, C. W.C. Kendall PhD, and S. C. Cunnane PhD Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis Can. Med. Assoc. J., January 15, 2008; 178(2): 157 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Surette PhD The science behind dietary omega-3 fatty acids Can. Med. Assoc. J., January 15, 2008; 178(2): 177 - 180. [Full Text] [PDF] |
||||
![]() |
I. Romieu, F. Castro-Giner, N. Kunzli, and J. Sunyer Air pollution, oxidative stress and dietary supplementation: a review Eur. Respir. J., January 1, 2008; 31(1): 179 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text] |
||||
![]() |
E. K. Kabagambe, M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, J. M. Peacock, I. B. Borecki, and D. K. Arnett Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study Clin. Chem., January 1, 2008; 54(1): 154 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Silletta, R. Marfisi, G. Levantesi, A. Boccanelli, C. Chieffo, M. Franzosi, E. Geraci, A. P. Maggioni, G. Nicolosi, C. Schweiger, et al. Coffee Consumption and Risk of Cardiovascular Events After Acute Myocardial Infarction: Results From the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione Trial Circulation, December 18, 2007; 116(25): 2944 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-T. Luu, J. Madden, P. C. Calder, R. F. Grimble, C. P. Shearman, T. Chan, N. Dastur, W. M. Howell, G. E. Rainger, and G. B. Nash Dietary Supplementation with Fish Oil Modifies the Ability of Human Monocytes to Induce an Inflammatory Response J. Nutr., December 1, 2007; 137(12): 2769 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz and C. A. Reardon Nutrition and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2499 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakabe, A. Shiroshita-Takeshita, A. Maguy, C. Dumesnil, A. Nigam, T.-K. Leung, and S. Nattel Omega-3 Polyunsaturated Fatty Acids Prevent Atrial Fibrillation Associated With Heart Failure but Not Atrial Tachycardia Remodeling Circulation, November 6, 2007; 116(19): 2101 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Haworth and B. D. Levy Endogenous lipid mediators in the resolution of airway inflammation Eur. Respir. J., November 1, 2007; 30(5): 980 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al. Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop Circulation, September 4, 2007; 116(10): e320 - e335. [Full Text] [PDF] |
||||
![]() |
A. Prabodh Shah, A. M. Ichiuji, J. K. Han, M. Traina, A. El-Bialy, S. Kamal Meymandi, and R. Yvonne Wachsner Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy Volunteers Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 213 - 219. [Abstract] [PDF] |
||||
![]() |
A. M Zivkovic, J B. German, and A. J Sanyal Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-E. Thomas, S.-M. Cooper, M. Graham, W. Boobier, J. Baker, and B. Davies Dietary habits of Welsh 12--13 year olds European Physical Education Review, June 1, 2007; 13(2): 247 - 257. [Abstract] [PDF] |
||||
![]() |
R. G Metcalf, M. J James, R. A Gibson, J. R. Edwards, J. Stubberfield, R. Stuklis, K. Roberts-Thomson, G. D Young, and L. G Cleland Effects of fish-oil supplementation on myocardial fatty acids in humans Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1222 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chrysohoou, D. B Panagiotakos, C. Pitsavos, J. Skoumas, X. Krinos, Y. Chloptsios, V. Nikolaou, and C. Stefanadis Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region--the ATTICA study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1385 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L Baker and C M. White Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies Ann. Pharmacother., April 1, 2007; 41(4): 587 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. von Schacky and W. S. Harris Cardiovascular benefits of omega-3 fatty acids Cardiovasc Res, January 15, 2007; 73(2): 310 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coronel, F. J.G. Wilms-Schopman, H. M. Den Ruijter, C. N. Belterman, C. A. Schumacher, T. Opthof, R. Hovenier, A. G. Lemmens, A. H.M. Terpstra, M. B. Katan, et al. Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts Cardiovasc Res, January 15, 2007; 73(2): 386 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Floras and A. Bagai Polyunsaturated Fatty Acids and the Post-Infarct Patient: A Recipe for Baroreflex Health? J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1607 - 1609. [Full Text] [PDF] |
||||
![]() |
M.F. Oliver Sudden cardiac death: the lost fatty acid hypothesis QJM, October 1, 2006; 99(10): 701 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
R. C. Oh, S. A. A. Beresford, and W. E. Lafferty The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and {omega}3 Fatty Acid Prescribing Behaviors J Am Board Fam Med, September 1, 2006; 19(5): 459 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids Nutr Clin Pract, August 1, 2006; 21(4): 323 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, W. S Harris, M. Chung, A. H Lichtenstein, E. M Balk, B. Kupelnick, H. S Jordan, and J. Lau n-3 Fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am. J. Clinical Nutrition, July 1, 2006; 84(1): 5 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Zaloga, N. Ruzmetov, K. A. Harvey, C. Terry, N. Patel, W. Stillwell, and R. Siddiqui (n-3) Long-Chain Polyunsaturated Fatty Acids Prolong Survival following Myocardial Infarction in Rats J. Nutr., July 1, 2006; 136(7): 1874 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Breslow n-3 Fatty acids and cardiovascular disease Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1477 - 1482S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoang and T. Canada {Omega}-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Controlled Trial Nutr Clin Pract, April 1, 2006; 21(2): 189 - 190. [Abstract] [Full Text] |
||||
![]() |
L. Hooper, R. L Thompson, R. A Harrison, C. D Summerbell, A. R Ness, H. J Moore, H. V Worthington, P. N Durrington, J. P T Higgins, N. E Capps, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review BMJ, April 1, 2006; 332(7544): 752 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Friedman and S. Moe Review of the Effects of Omega-3 Supplementation in Dialysis Patients Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 182 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Serhan, K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes J. Immunol., February 1, 2006; 176(3): 1848 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Xiao, L. Ma, S.-Y. Wang, M. E. Josephson, G. K. Wang, J. P. Morgan, and A. Leaf Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids Am J Physiol Cell Physiol, February 1, 2006; 290(2): C362 - C370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Boos, R. A. Anderson, and G. Y.H. Lip Is atrial fibrillation an inflammatory disorder? Eur. Heart J., January 2, 2006; 27(2): 136 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF] |
||||
![]() |
C. M. Albert, K. Oh, W. Whang, J. E. Manson, C. U. Chae, M. J. Stampfer, W. C. Willett, and F. B. Hu Dietary {alpha}-Linolenic Acid Intake and Risk of Sudden Cardiac Death and Coronary Heart Disease Circulation, November 22, 2005; 112(21): 3232 - 3238. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raitt, W. E. Connor, C. Morris, and J. McAnulty Fish Oil Supplementation and Arrhythmias--Reply JAMA, November 2, 2005; 294(17): 2165 - 2166. [Full Text] [PDF] |
||||
![]() |
J.A. Iestra, D. Kromhout, Y.T. van der Schouw, D.E. Grobbee, H.C. Boshuizen, and W.A. van Staveren Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review Circulation, August 9, 2005; 112(6): 924 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Macchia, G. Levantesi, M. G. Franzosi, E. Geraci, A. P. Maggioni, R. Marfisi, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids Eur J Heart Fail, August 1, 2005; 7(5): 904 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Raitt, W. E. Connor, C. Morris, J. Kron, B. Halperin, S. S. Chugh, J. McClelland, J. Cook, K. MacMurdy, R. Swenson, et al. Fish Oil Supplementation and Risk of Ventricular Tachycardia and Ventricular Fibrillation in Patients With Implantable Defibrillators: A Randomized Controlled Trial JAMA, June 15, 2005; 293(23): 2884 - 2891. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Maki, M. E. Van Elswyk, D. McCarthy, S. P. Hess, P. E. Veith, M. Bell, P. Subbaiah, and M. H. Davidson Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol J. Am. Coll. Nutr., June 1, 2005; 24(3): 189 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Calo, L. Bianconi, F. Colivicchi, F. Lamberti, M. L. Loricchio, E. de Ruvo, A. Meo, C. Pandozi, M. Staibano, and M. Santini N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Controlled Trial J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1723 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Colquhoun Omega-3 Fatty Acids for Secondary Prevention J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1552 - 1552. [Full Text] [PDF] |
||||
![]() |
F. Holguin, M. M. Tellez-Rojo, M. Lazo, D. Mannino, J. Schwartz, M. Hernandez, and I. Romieu Cardiac Autonomic Changes Associated With Fish Oil vs Soy Oil Supplementation in the Elderly Chest, April 1, 2005; 127(4): 1102 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Geelen, I. A Brouwer, E. G Schouten, A. C Maan, M. B Katan, and P. L Zock Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans Am. J. Clinical Nutrition, February 1, 2005; 81(2): 416 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schwarz and H. Leweling Multiple sclerosis and nutrition Multiple Sclerosis, February 1, 2005; 11(1): 24 - 32. [Abstract] [PDF] |
||||
![]() |
L. Frost and P. Vestergaard n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study Am. J. Clinical Nutrition, January 1, 2005; 81(1): 50 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Oh Practical Applications of Fish Oil ({Omega}-3 Fatty Acids) in Primary Care J Am Board Fam Med, January 1, 2005; 18(1): 28 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Christensen, S. Riahi, E. B. Schmidt, H. Mølgaard, A. K. Pedersen, F. Heath, J. C. Nielsen, and E. Toft n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators Europace, January 1, 2005; 7(4): 338 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gaede and O. Pedersen Intensive Integrated Therapy of Type 2 Diabetes: Implications for Long-Term Prognosis Diabetes, December 1, 2004; 53(suppl_3): S39 - S47. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Harris, S. A. Sands, S. L. Windsor, H. A. Ali, T. L. Stevens, A. Magalski, C. B. Porter, and A. M. Borkon Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients: Correlation With Erythrocytes and Response to Supplementation Circulation, September 21, 2004; 110(12): 1645 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tavazzi, G. Tognoni, M. G. Franzosi, R. Latini, A. P. Maggioni, R. Marchioli, G. L. Nicolosi, M. Porcu, and on behalf of the GISSI-HF investigators Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure Eur J Heart Fail, August 1, 2004; 6(5): 635 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Surette, M. Edens, F. H. Chilton, and K. M. Tramposch Dietary Echium Oil Increases Plasma and Neutrophil Long-Chain (n-3) Fatty Acids and Lowers Serum Triacylglycerols in Hypertriglyceridemic Humans J. Nutr., June 1, 2004; 134(6): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Dwyer, H. Allayee, K. M. Dwyer, J. Fan, H. Wu, R. Mar, A. J. Lusis, and M. Mehrabian Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis N. Engl. J. Med., January 1, 2004; 350(1): 29 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G.F. Cleland, N. Freemantle, G. Kaye, M. Nasir, P. Velavan, K. Lalukota, T. Mudawi, R. Shelton, A. L. Clark, and A. P. Coletta Clinical trials update from the American Heart Association meeting: {Omega}-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE Eur J Heart Fail, January 1, 2004; 6(1): 109 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. O'Keefe Jr and L. Cordain Cardiovascular Disease Resulting From a Diet and Lifestyle at Odds With Our Paleolithic Genome: How to Become a 21st-Century Hunter-Gatherer Mayo Clin. Proc., January 1, 2004; 79(1): 101 - 108. [Abstract] [PDF] |
||||
![]() |
W. S. Harris, J. H. O'Keefe Jr, and S. M. Grundy Preventive Use of N-3 Fatty Acids * Response Circulation, November 11, 2003; 108 (19): e139 - e139. [Full Text] [PDF] |
||||
![]() |
K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dallongeville, J. Yarnell, P. Ducimetiere, D. Arveiler, J. Ferrieres, M. Montaye, G. Luc, A. Evans, A. Bingham, B. Hass, et al. Fish Consumption Is Associated With Lower Heart Rates Circulation, August 19, 2003; 108(7): 820 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Anderson Lipid-lowering therapy for prevention of ventricular tachyarrhythmias J. Am. Coll. Cardiol., July 2, 2003; 42(1): 88 - 92. [Full Text] [PDF] |
||||
![]() |
A. T Erkkila, S. Lehto, K. Pyorala, and M. I. Uusitupa n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease Am. J. Clinical Nutrition, July 1, 2003; 78(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.W. Lee and G.Y.H. Lip The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease QJM, July 1, 2003; 96(7): 465 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Siscovick, R. N. Lemaitre, and D. Mozaffarian The Fish Story: A Diet-Heart Hypothesis With Clinical Implications: n-3 Polyunsaturated Fatty Acids, Myocardial Vulnerability, and Sudden Death Circulation, June 3, 2003; 107(21): 2632 - 2634. [Full Text] [PDF] |
||||
![]() |
A. Leaf, J. X. Kang, Y.-F. Xiao, and G. E. Billman Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils Circulation, June 3, 2003; 107(21): 2646 - 2652. [Full Text] [PDF] |
||||
![]() |
S. Hong, K. Gronert, P. R. Devchand, R.-L. Moussignac, and C. N. Serhan Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells. AUTACOIDS IN ANTI-INFLAMMATION J. Biol. Chem., April 18, 2003; 278(17): 14677 - 14687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grundy N-3 Fatty Acids: Priority for Post-Myocardial Infarction Clinical Trials Circulation, April 15, 2003; 107(14): 1834 - 1836. [Full Text] [PDF] |
||||
![]() |
F. B. Hu, E. Cho, K. M. Rexrode, C. M. Albert, and J. E. Manson Fish and Long-Chain {omega}-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women Circulation, April 15, 2003; 107(14): 1852 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ziouzenkova, S. Perrey, L. Asatryan, J. Hwang, K. L. MacNaul, D. E. Moller, D. J. Rader, A. Sevanian, R. Zechner, G. Hoefler, et al. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase PNAS, March 4, 2003; 100(5): 2730 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grodstein, T. B. Clarkson, and J. E. Manson Understanding the Divergent Data on Postmenopausal Hormone Therapy N. Engl. J. Med., February 13, 2003; 348(7): 645 - 650. [Full Text] [PDF] |
||||
![]() |
W. S Harris n-3 Long-chain polyunsaturated fatty acids reduce risk of coronary heart disease death: extending the evidence to the elderly Am. J. Clinical Nutrition, February 1, 2003; 77(2): 279 - 280. [Full Text] [PDF] |
||||
![]() |
R. N Lemaitre, I. B King, D. Mozaffarian, L. H Kuller, R. P Tracy, and D. S Siscovick n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study Am. J. Clinical Nutrition, February 1, 2003; 77(2): 319 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): e20 - 30. [Full Text] [PDF] |
||||
![]() |
OMEGA-3 FATTY ACIDS LINKED WITH LOWER SUDDEN DEATH AND CHD RISKS Journal Watch Cardiology, January 1, 2003; 2003(101): 5 - 5. [Full Text] |
||||
![]() |
F. B. Hu and W. C. Willett Optimal Diets for Prevention of Coronary Heart Disease JAMA, November 27, 2002; 288(20): 2569 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Circulation, November 19, 2002; 106(21): 2747 - 2757. [Full Text] [PDF] |
||||
![]() |
C. N. Serhan, S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R.-L. Moussignac Resolvins: A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals J. Exp. Med., October 21, 2002; 196(8): 1025 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Geelen, I. A. Brouwer, P. L. Zock, J. A. Kors, C. A. Swenne, M. B. Katan, and E. G. Schouten (n-3) Fatty Acids Do Not Affect Electrocardiographic Characteristics of Healthy Men and Women J. Nutr., October 1, 2002; 132(10): 3051 - 3054. [Abstract] [Full Text] [PDF] |
||||
![]() |
Omega-3 Fatty Acids Linked with Lower Sudden Death and CHD Risks Journal Watch Cardiology, May 31, 2002; 2002(531): 1 - 1. [Full Text] |
||||
![]() |
A. Leaf On the Reanalysis of the GISSI-Prevenzione Circulation, April 23, 2002; 105(16): 1874 - 1875. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |